Annual CFO
-$9.80 M
-$2.26 M-29.95%
31 December 2023
Summary:
Acurx Pharmaceuticals annual cash flow from operations is currently -$9.80 million, with the most recent change of -$2.26 million (-29.95%) on 31 December 2023. During the last 3 years, it has fallen by -$6.45 million (-192.42%). ACXP annual CFO is now -192.42% below its all-time high of -$3.35 million, reached on 31 December 2020.ACXP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.19 M
+$690.50 K+23.97%
30 September 2024
Summary:
Acurx Pharmaceuticals quarterly cash flow from operations is currently -$2.19 million, with the most recent change of +$690.50 thousand (+23.97%) on 30 September 2024. Over the past year, it has dropped by -$96.30 thousand (-4.60%). ACXP quarterly CFO is now -563.98% below its all-time high of -$329.80 thousand, reached on 30 June 2021.ACXP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$12.33 M
-$96.30 K-0.79%
30 September 2024
Summary:
Acurx Pharmaceuticals TTM cash flow from operations is currently -$12.33 million, with the most recent change of -$96.30 thousand (-0.79%) on 30 September 2024. Over the past year, it has dropped by -$5.23 million (-73.71%). ACXP TTM CFO is now -1271.16% below its all-time high of -$899.30 thousand, reached on 01 March 2020.ACXP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACXP Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.9% | -4.6% | -73.7% |
| 3 y3 years | -192.4% | +16.9% | -175.7% |
| 5 y5 years | - | - | - |
ACXP Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -192.4% | at low | -46.4% | +47.8% | -175.7% | at low |
| 5 y | 5 years | -192.4% | at low | -564.0% | +47.8% | -1271.2% | at low |
| alltime | all time | -192.4% | at low | -564.0% | +47.8% | -1271.2% | at low |
Acurx Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.19 M(-24.0%) | -$12.33 M(+0.8%) |
| June 2024 | - | -$2.88 M(-6.0%) | -$12.23 M(+11.9%) |
| Mar 2024 | - | -$3.06 M(-27.0%) | -$10.93 M(+11.5%) |
| Dec 2023 | -$9.80 M(+29.9%) | -$4.20 M(+100.5%) | -$9.80 M(+38.1%) |
| Sept 2023 | - | -$2.09 M(+32.8%) | -$7.10 M(-1.2%) |
| June 2023 | - | -$1.58 M(-18.4%) | -$7.19 M(-5.4%) |
| Mar 2023 | - | -$1.93 M(+29.2%) | -$7.60 M(+0.8%) |
| Dec 2022 | -$7.54 M | -$1.50 M(-31.4%) | -$7.54 M(-0.1%) |
| Sept 2022 | - | -$2.18 M(+9.5%) | -$7.55 M(-5.7%) |
| June 2022 | - | -$1.99 M(+6.1%) | -$8.00 M(+26.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$1.88 M(+25.0%) | -$6.34 M(+26.5%) |
| Dec 2021 | -$5.01 M(+49.6%) | -$1.50 M(-43.1%) | -$5.01 M(+12.1%) |
| Sept 2021 | - | -$2.64 M(+699.5%) | -$4.47 M(+72.3%) |
| June 2021 | - | -$329.80 K(-39.7%) | -$2.60 M(-13.5%) |
| Mar 2021 | - | -$547.10 K(-43.0%) | -$3.00 M(-10.5%) |
| Dec 2020 | -$3.35 M(-15.9%) | -$959.80 K(+26.5%) | -$3.35 M(+40.1%) |
| Sept 2020 | - | -$758.80 K(+3.4%) | -$2.39 M(+46.5%) |
| June 2020 | - | -$733.80 K(-18.4%) | -$1.63 M(+81.6%) |
| Mar 2020 | - | -$899.30 K | -$899.30 K |
| Dec 2019 | -$3.99 M | - | - |
FAQ
- What is Acurx Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals annual CFO year-on-year change?
- What is Acurx Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals quarterly CFO year-on-year change?
- What is Acurx Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals TTM CFO year-on-year change?
What is Acurx Pharmaceuticals annual cash flow from operations?
The current annual CFO of ACXP is -$9.80 M
What is the all time high annual CFO for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high annual cash flow from operations is -$3.35 M
What is Acurx Pharmaceuticals annual CFO year-on-year change?
Over the past year, ACXP annual cash flow from operations has changed by -$2.26 M (-29.95%)
What is Acurx Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ACXP is -$2.19 M
What is the all time high quarterly CFO for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high quarterly cash flow from operations is -$329.80 K
What is Acurx Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ACXP quarterly cash flow from operations has changed by -$96.30 K (-4.60%)
What is Acurx Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ACXP is -$12.33 M
What is the all time high TTM CFO for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high TTM cash flow from operations is -$899.30 K
What is Acurx Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ACXP TTM cash flow from operations has changed by -$5.23 M (-73.71%)